Interleukin-6 regulates pancreatic α-cell mass expansion
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) is systemically elevated in obesity and is a predictive factor to develop type 2 diabetes. Pancreatic islet pathology in type 2 diabetes is characterized by reduced β-cell function and mass, an increased proportion of α-cells relative to β-cells, and α-cell dysfunction. Here we show that the α cell is a primary target of IL-6 actions. Beginning with investigating the tissue-specific expression pattern of the IL-6 receptor (IL-6R) in both mice and rats, we find the highest expression of the IL-6R in the endocrine pancreas, with highest expression on the α-cell. The islet IL-6R is functional, and IL-6 acutely regulates both pro-glucagon mRNA and glucagon secretion in mouse and human islets, with no acute effect on insulin secretion. Furthermore, IL-6 stimulates α-cell proliferation, prevents apoptosis due to metabolic stress, and regulates α-cell mass in vivo . Using IL-6 KO mice fed a high-fat diet, we find that IL-6 is necessary for high-fat diet-induced increased α-cell mass, an effect that occurs early in response to diet change. Further, after high-fat diet feeding, IL-6 KO mice without expansion of α-cell mass display decreased fasting glucagon levels. However, despite these α-cell effects, high-fat feeding of IL-6 KO mice results in increased fed glycemia due to impaired insulin secretion, with unchanged insulin sensitivity and similar body weights. Thus, we conclude that IL-6 is necessary for the expansion of pancreatic α-cell mass in response to high-fat diet feeding, and we suggest that this expansion may be needed for functional β-cell compensation to increased metabolic demand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interleukin (IL)-6, which is both an adipokine and myokine,287 was shown to influence the pancreas by controlling the expression of pro-glucagon mRNA as well as glucagon secretion. It also increases α-cell proliferation and islet mass while protecting the pancreas from metabolic stress-induced apoptosis.288”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [288]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationLiver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 1×
“Upon IL-6 binding to its receptor, the IL-6R forms a complex with the signal transducing transmembrane glycoprotein, gp130, and signals are transduced via activation of STAT3 and ERK signaling, regulating downstream targets such as c-myc and bcl-2 (7, 13, 14).”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“IL-6 KO mice are known to become obese and glucose intolerant after 6–9 months of age due to lack of IL-6 central nervous system effects (10).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citation共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値
Whittaker, P. G., Morgan, M. R., Dean, P., Cameron, E., & Lind, T. (1980) · The Lancet · Cited by 724
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673 · cited 5×
“Since gp130 is ubiquitously expressed, specificity of IL-6R signaling is mainly mediated by tissue specific IL-6R expression, and/or the local action of soluble IL-6Rs (7).”
BackgroundInfluentialEvidence that interleukin-6 is produced in human skeletal muscle during prolonged running
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.949bp.x · Cited by 673 · cited 2×
“Proc Natl Acad Sci USA 104(8):2861–2866.”
Background
Research works printed but not linked: 1
- Winzell MS, Ahren J, Renstrom E, Ahren B. Beta cell specific overexpression of glucagon receptors results in improved insulin secretion in response to glucose but impaired response to glucagon. Diabetologia. 2007;50:S28. [Google Scholar]
Cited by
Items 101–200 of 281
The regulation of pre- and post-maturational plasticity of mammalian islet cell mass
Mezza, T., & Kulkarni, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3251-7 · Cited by 49
Intra-islet glucagon-like peptide 1
Fava, G. E., Dong, E. W., & Wu, H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.016 · Cited by 45
Pancreatic inflammation and increased islet macrophages in insulin-resistant juvenile primates
Nicol, L. E., Grant, W. F., Comstock, S. M., Nguyen, M. L., Smith, M. S., Grove, K. L., & Marks, D. L. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0424 · Cited by 44
“Although our study did not address isletspecific cytokine levels, regardless of an exocrine or endocrine source, the rodent islet has proven to be affected by the presence of cytokines as these micro-organs express several cytokine receptors including IL6 (Ellingsgaard et al. 2008).”
Chen, Z., Liu, X., & Kenny, P. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106860 · Cited by 49
“Furthermore, higher levels of interleukin-6 in the serum has been shown to enhance the production of GLP-1 to maintain insulin secretion and glucose homeostasis [104,105].”
Townsend, L. K., Medak, K. D., Peppler, W. T., Meers, G. M.-E., Rector, R. S., LeBlanc, P. J., & Wright, D. C. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092510 · Cited by 46
“IL-6 may achieve some of its metabolic benefits via classical signaling in the liver, the tissue with one of the greatest concentrations of IL-6 receptors in the body, at least in mice and rats (8).”
BackgroundMaternal high-fat diet is associated with altered pancreatic remodelling in mice offspring
Gregório, B. M., Souza‐Mello, V., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0382-9 · Cited by 47
Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice
Pini, M., Rhodes, D., & Fantuzzi, G. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.015 · Cited by 42
Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1
Campbell, S. A., Johnson, J., & Light, P. E. (2021) · Islets · doi:10.1080/19382014.2021.1889941 · Cited by 42
Nunemaker, C. S. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2846570 · Cited by 47
“However, IL-6 has also been associated with beneficial effects of exercise (reviewed in [68]) and with improving islet function [69, 70], resulting”
BackgroundKnudsen, S. H., & Pedersen, B. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0642-1 · Cited by 41
Fasting blood glucose levels in patients with different types of diseases
Zhang, Q., Zhao, G., Yang, N., & Zhang, L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.01.004 · Cited by 50
Rajendran, S. H., Anquetil, F., Quesada‐Masachs, E., Graef, M., Gonzalez, N., McArdle, S., Chu, T., Krogvold, L., Dahl‐Jørgensen, K., & von Herrath, M. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108320 · Cited by 43
“In contrast, IL-6 has been shown to have various functions in metabolic regulation such as induction of GLP-1 secretion and expansion in alpha cells [17, 18], regulation of glucose homeostasis [19] and exerciseinduced loss of visceral fat [20].”
BackgroundFritsche, L., Hoene, M., Lehmann, R., Ellingsgaard, H., Hennige, A. M., Pohl, A. K., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · Diabetologia · doi:10.1007/s00125-010-1754-4 · Cited by 45
Self-citationSartorius, T., Lutz, S. Z., Hoene, M., Waak, J., Peter, A., Weigert, C., Rammensee, H., Kahle, P. J., Häring, H., & Hennige, A. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-191023 · Cited by 39
Chu, K. Y., Li, H., Wada, K., & Johnson, J. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2323-1 · Cited by 37
“The increased number of alpha cells seen in control diet-fed Uchl1 mice may represent an acceleration of the previously reported IL6-dependent alpha cell hyperplasia [40].”
BackgroundResultThe Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
Martínez, M. S., Manzano, A., Olivar, L. C., Nava, M., Salazar, J. J., D’Marco, L., Ortíz, R., Chacín, M., Guerrero‐Wyss, M., de Bravo, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179504 · Cited by 42
Merino, B., Alonso‐Magdalena, P., Lluesma, M., Ñeco, P., González, A., Marroquí, L., García‐Arévalo, M., Nadal, Á., & Quesada, I. (2015) · Scientific Reports · doi:10.1038/srep11622 · Cited by 38
Glucagon in type 2 diabetes: Friend or foe?
Caruso, I., Marrano, N., Biondi, G., Genchi, V. A., D'Oria, R., Sorice, G. P., Perrini, S., Cignarelli, A., Natalicchio, A., Laviola, L., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3609 · Cited by 35
Zhang, J., Zheng, Y., Martens, L., & Pfeiffer, A. F. H. (2023) · Nutrients · doi:10.3390/nu15183913 · Cited by 40
“Glucolipotoxicity conditions, such as combining palmitate with high glucose levels, can induce apoptosis in rodent α-cells [156].”
BackgroundChristensen, C. S., Christensen, D. P., Lundh, M., Dahllöf, M. S., Haase, T. N., Velasquez, J. M., Laye, M. J., Mandrup-Poulsen, T., & Solomon, T. P. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4506 · Cited by 34
Targeting gp130 to prevent inflammation and promote insulin action
Kraakman, M. J., Allen, T. L., Whitham, M., Iliades, P., Kammoun, H. L., Estevez, E., Lancaster, G. I., & Febbraio, M. A. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12170 · Cited by 33
The Regenerative Activity of Interleukin-6
Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-308-4_4 · Cited by 34
Agarwal, P., Brar, N., Morriseau, T. S., Kereliuk, S. M., Fonseca, M. A., Cole, L. K., Jha, A., Xiang, B., Hunt, K. L., Seshadri, N., et al. (2019) · Endocrinology · doi:10.1210/en.2019-00232 · Cited by 34
Adipose tissue-derived mediators of systemic inflammation and metabolic control
Alexaki, V. I. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100560 · Cited by 37
Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas
Barnes, T. M., Otero, Y. F., Elliott, A. D., Locke, A. D., Malabanan, C. M., Coldren, A., Briššová, M., Piston, D. W., & McGuinness, O. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00343.2014 · Cited by 35
Metabolic response to endotoxin in vivo in the conscious mouse: role of interleukin-6
Tweedell, A. D., Mulligan, K. X., Martel, J. E., Chueh, F., Santomango, T. S., & McGuinness, O. P. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.022 · Cited by 37
Excessive Food Intake, Obesity and Inflammation Process in Zucker fa/fa Rat Pancreatic Islets
Chentouf, M., Dubois, G., Jahannaut, C., Castex, F., Lajoix, A., Gross, R., & Péraldi‐Roux, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022954 · Cited by 35
Ben-Zvi, D., Barrandon, O., Hadley, S., Blum, B., Peterson, Q. P., & Melton, D. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513872112 · Cited by 34
Sustained Reversal of Diabetes Following Islet Transplantation to Striated Musculature in the Rat
Lund, T., Korsgren, O., Aursnes, I. A. S., Scholz, H., & Foss, A. E. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.11.009 · Cited by 36
“IL-6 and IL-8 are pro-inflammatory cytokines/chemokines expressed and produced bymyocytes under stress [34–37], and have been implicated in inflammation-induced islet dysfunction [38–43].”
BackgroundMetabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line
Sancho, V., Daniele, G., Lucchesi, D., Lupi, R., Ciccarone, A., Penno, G., Bianchi, C., Dardano, A., Miccoli, R., & Prato, S. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187836 · Cited by 34
Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
Bozadjieva-Kramer, N., Lubaczeuski, C., Blandino-Rosano, M., Barker, G. P., Gittes, G. K., Caicedo, A., & Bernal‐Mizrachi, E. (2020) · Diabetes · doi:10.2337/db20-0440 · Cited by 35
Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg
Langlois, A., Dumond, A., Vion, J., Pinget, M., & Bouzakri, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.836344 · Cited by 35
“Studies on the effects of IL-6 on b-cell function have shown mixed results, with some finding a negative effect (94) and others a positive effect on insulin production (95, 96).”
ResultGillies, N. A., Pendharkar, S. A., Singh, R. G., Windsor, J. A., Bhatia, M., & Petrov, M. S. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1308382 · Cited by 33
Yang, K., Zhang, Y., Ding, J., Li, Z., Zhang, H., & Zou, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1377322 · Cited by 34
Metabolic impact of glucagon deficiency
Hayashi, Y. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01456.x · Cited by 36
Parthsarathy, V., Irwin, N., Hasib, A., Martin, C. M., McClean, S., Bhat, V. K., Ng, M. T., Flatt, P. R., & Gault, V. A. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.015 · Cited by 31
Abdel‐Hamid, A. A. M., & Firgany, A. E. L. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.06.002 · Cited by 30
Interorgan Crosstalk Contributing toβ-Cell Dysfunction
Tanabe, K., Amo-Shiinoki, K., Hatanaka, M., & Tanizawa, Y. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3605178 · Cited by 33
Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
Fujita, Y., Kozawa, J., Iwahashi, H., Yoneda, S., Uno, S., Eguchi, H., Nagano, H., Imagawa, A., & Shimomura, I. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12841 · Cited by 34
Bimodal impact of skeletal muscle on pancreatic β‐cell function in health and disease
Plomgaard, P., Halban, P. A., & Bouzakri, K. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01641.x · Cited by 28
Self-citationvan Poppel, M. N. M., Peinhaupt, M., Eekhoff, E. M. W., Heinemann, Á., Oostdam, N., Wouters, M. G. A. J., van Mechelen, W., & Desoyé, G. (2014) · Diabetes Care · doi:10.2337/dc13-2140 · Cited by 32
Nicoletti-Carvalho, J. E., Nogueira, T. C. A., Gorjão, R., Bromati, C. R., Yamanaka, T. S., Boschero, A. C., Velloso, L. A., Curi, R., Anhê, G. F., & Bordin, S. A. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0356 · Cited by 29
“2004), and to increase cell death in primary islets treated with FFAs (Ellingsgaard et al. 2008).”
BackgroundChen, X., Shao, J., Brandenburger, I., Qian, W., Hahnefeld, L., Bonnavion, R., Cho, H., Wang, S., Hidalgo, J., Wettschureck, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58706-5 · Cited by 31
King, R., Hill, J. L., Saha, B., Tong, Y., Strutt, B. J., Russell, M. A., Morgan, N. G., Richardson, S. J., & Hill, D. J. (2019) · Nutrients · doi:10.3390/nu11030605 · Cited by 31
Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
Wang, Q., Liang, X., & Wang, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00485 · Cited by 29
Guardado‐Mendoza, R., Jiménez-Ceja, L. M., Majluf‐Cruz, A., Kamath, S., Fiorentino, T. V., Casiraghi, F., Velazquez, A. O. C., DeFronzo, R. A., Dick, E. J., Davalli, A. M., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.205 · Cited by 28
Sprouse, C., Gordish‐Dressman, H., Suer, F. E., Lipof, J. S., Moeckel‐Cole, S., Patel, R. R., Adham, K., Larkin, J. S., Hubal, M. J., Kearns, A. K., et al. (2013) · Diabetes · doi:10.2337/db13-1150 · Cited by 33
Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
Muzio, C. D., Cipriani, P., & Ruscitti, P. (2022) · BioDrugs · doi:10.1007/s40259-022-00561-7 · Cited by 28
Chen, W. K., Cui, W., Wu, J., Zheng, W., Sun, X., Zhang, J., Shang, H., Yuan, Y., Li, X., Wang, J., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155641 · Cited by 28
Molecular Pathways Underlying the Pathogenesis of Pancreatic α-Cell Dysfunction
Kawamori, D., Welters, H. J., & Kulkarni, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_18 · Cited by 27
Growth factor signalling in the regulation of α ‐cell fate
Kawamori, D., Akiyama, M., Hu, J., Hambro, B., & Kulkarni, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01442.x · Cited by 27
Wang, C., & Tsai, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.238 · Cited by 28
Unravelling the broader complexity of IL-6 involvement in health and disease
Jenkins, R. L., Hughes, S. T. O., Figueras, A. C., & Jones, S. A. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155684 · Cited by 26
Li, X., Du, W., Ma, F. X., Feng, X., Bayard, F., & Han, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128647 · Cited by 29
Remission of Diabetes Mellitus in Cats Cannot be Predicted by the Arginine Stimulation Test
Tschuor, F., Zini, E., Schellenberg, S., Wenger, M., Kaufmann, K., Furrer, D., Lutz, T. A., & Reusch, C. E. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0649.x · Cited by 25
Legaard, G. E., & Pedersen, B. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814593-7.00013-x · Cited by 32
Exocrine pancreas regeneration modifies original pancreas to alleviate diabetes in mouse models
Kou, X., Liu, J., Wang, D., Yu, M., Li, C., Lu, L., Chen, C., Liu, D., Yu, W., Yu, T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg9170 · Cited by 23
The human α cell in health and disease
Pettway, Y. D., Saunders, D. C., & Briššová, M. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0298 · Cited by 24
Periodontitis affects glucoregulatory hormones in severely obese individuals
Solini, A., Suvan, J. E., Santini, E., Gennai, S., Seghieri, M., Masi, S., Petrini, M., D’Aiuto, F., & Graziani, F. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0253-4 · Cited by 23
Zhang, X., Luo, S., Wang, M., Huang, Q. M., Fang, W., Li, J., Liu, T., Zhang, Y., Deng, Z., Liu, C.-L., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.013 · Cited by 22
Hosni, A., Abdel‐Moneim, A., Hussien, M., Zanaty, M. I., Eldin, Z. E., & El‐Shahawy, A. A. G. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.048 · Cited by 21
Hill, T. G., & Hill, D. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074070 · Cited by 26
“This is likely to involve an increased inflammatory environment within the islets during T2D, since interleukin-6 (IL-6) increased both alpha-cell hyperplasia and GLP-1 release [173,174].”
BackgroundGlycoprotein 130 Receptor Signaling Mediates α-Cell Dysfunction in a Rodent Model of Type 2 Diabetes
Chow, S., Speck, M., Yoganathan, P., Nąckiewicz, D., Hansen, A. M. K., Ladefoged, M., Rabe, B., Rose‐John, S., Voshol, P. J., Lynn, F. C., et al. (2014) · Diabetes · doi:10.2337/db13-1121 · Cited by 21
Self-citationLee, Y.-S., & Jun, H. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.24492 · Cited by 22
Calcaterra, V., Magenes, V. C., Bianchi, A., Rossi, V., Gatti, A., Marin, L., Vandoni, M., & Zuccotti, G. (2024) · Life · doi:10.3390/life14091198 · Cited by 23
“IL-6 [4,7,23,28,36,37,39–41] It is involved in autocrine and paracrine signaling in skeletal muscle, particularly activating the STAT3 pathway, which is important for hypertrophic muscle growth and myogenesis.”
BackgroundDusaulcy, R., Handgraaf, S., Visentin, F., Vesin, C., Philippé, J., & Gosmain, Y. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.004 · Cited by 20
“Indeed, even if alpha-cells proliferate during HFD [51], alpha-cells number remains unchanged after 16 weeks of HFD feeding while a strong increase of beta-cell number is observed [8].”
BackgroundWoodland, D. C., Liu, W., Leong, J., Sears, M. L., Luo, P., & Chen, X. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00092.2016 · Cited by 25
Marques, E., Formato, E., Liang, W., Leonard, E., & Timme‐Laragy, A. R. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13236 · Cited by 20
“Previous work has found that IL6, an inflammatory cytokine elevated in T2DM,(40) stimulates α-cell proliferation.(13) Interestingly, in α-cells from T2DM donors, several cytokines, including IL6, IL4, IL5, IL13, and IL15, were identified as upstream regulators.”
BackgroundLehrskov, L. L., Christensen, R. H., Wedell‐Neergaard, A., Legaard, G. E., Dorph, E., Larsen, M. K., Henneberg, M., Launbo, N., Fagerlind, S. R., Seide, S. K., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01249 · Cited by 19
“That IL-6 receptor blockade increased glucagon secretion is quite contradictory to studies in rodent and human alpha cells (Ellingsgaard et al., 2008; Fernández-Millán et al., 2013) and to in vivo studies in rodents (Tweedell et al.”
BackgroundSelf-citationYang, X., Ding, W., Chen, Z., Lai, K., & Liu, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3762 · Cited by 19
“119,120 Additionally, autophagy's role in clearing damaged cellular components and reducing cellular stress helps alleviate the inflammatory state in the pancreas, further contributing to enhanced insulin secretion.”
BackgroundTributyltin exposure disturbs hepatic glucose metabolism in male mice
Xu, J., Ou, K., Chen, C., Li, B., Guo, J., Zuo, Z., & Wang, C. (2019) · Toxicology · doi:10.1016/j.tox.2019.152242 · Cited by 19
Truchan, N. A., Fenske, R. J., Sandhu, H. K., Weeks, A. M., Patibandla, C., Wancewicz, B., Pabich, S., Reuter, A., Harrington, J. M., Brill, A. L., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00045 · Cited by 19
Glucagon: The renewal of an old hormone in the pathophysiology of diabetes (胰升糖素:一种老激素在糖尿病病理生理中的新作用)
Gosmain, Y., Masson, M. H., & Philippé, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12022 · Cited by 19
Horváth, L., Pekár, M., Švagera, Z., Horká, V., Mráz, M., & Bužga, M. (2025) · Physiological Research · doi:10.33549/physiolres.935751 · Cited by 22
Xu, J., Xie, L., Fan, R., Shi, X., Xu, W., Dong, K., Ma, D., Yan, Y., Zhang, S., Sun, N., et al. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01525-6 · Cited by 19
Navia, B., Ferrer, B., Giralt, M., Comes, G., Carrasco, J., Molinero, A., Quintana, A., Leclerc, J., Viollet, B., Señarís, R. M., et al. (2014) · Acta Physiologica · doi:10.1111/apha.12328 · Cited by 16
González-Casimiro, C. M., Cámara-Torres, P., Merino, B., Diez‐Hermano, S., Postigo, T., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Cells · doi:10.3390/cells10092446 · Cited by 15
WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability
Boerner, B. P., George, N. M., Mir, S. U. R., & Sarvetnick, N. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0449 · Cited by 15
Yu, X., Li, M., & Li, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118846 · Cited by 14
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population
Chen, Y., Jiang, Q., Xing, X., Yuan, T., & Li, P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09914-9 · Cited by 16
Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice
Takasu, T., & Takakura, S. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-01007 · Cited by 14
Tanday, N., Moffett, R. C., Gault, V. A., Flatt, P. R., & Irwin, N. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3384 · Cited by 16
Al‐Abdulla, R., Ferrero, H., Boronat‐Belda, T., Soriano, S., Quesada, I., & Alonso‐Magdalena, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021044 · Cited by 14
“However, prolonged elevated IL-6 circulating levels may lead to α-cell failure [35].”
BackgroundNovel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning
Gutteridge, A., Rukstalis, J. M., Ziemek, D., Tié, M., Ji, L., Ramos-Zayas, R., Nardone, N. A., Norquay, L., Brenner, M. B., Tang, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056024 · Cited by 14
Clementi, A. H., Gaudy, A. M., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.004 · Cited by 18
Lee, Y.-S., Song, G. J., & Jun, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.605110 · Cited by 17
Insights on the Role of Putative Muscle-Derived Factors on Pancreatic Beta Cell Function
Mizgier, M. L., Fernández‐Verdejo, R., Cherfan, J., Pinget, M., Bouzakri, K., & Galgani, J. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01024 · Cited by 16
IL-6-dependent proliferation of alpha cells in mice with partial pancreatic-duct ligation
Cai, Y., Yuchi, Y., Groef, S. D., Coppens, V., Leuckx, G., Baeyens, L., de Casteele, M. V., & Heimberg, H. (2014) · Diabetologia · doi:10.1007/s00125-014-3242-8 · Cited by 13
“Alpha cell proliferation is regulated by interleukin-6 in PDL As IL-6-receptor (IL-6R) is highly expressed in alpha cells, IL-6 can stimulate alpha cell mass expansion [18] and IL-6 production is increased in PDL [17, 23], we investigated whether IL-6 could be responsible for the increase in alpha cell proliferation i…”
BackgroundInfluentialNrf2 modulates the benefits of evening exercise in type 2 diabetes
Fasipe, B., & Laher, I. (2023) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2023.09.001 · Cited by 13
“68,69 IL-6 also activates AMPK (Fig.”
Fernández‐Millán, E., de Toro‐Martín, J., Lizárraga-Mollinedo, E., Escrivá, F., & Álvarez, C. (2013) · Diabetologia · doi:10.1007/s00125-013-2862-8 · Cited by 17
Lou, P., Lucchinetti, E., Wawrzyniak, P., Morsy, Y., Wawrzyniak, M., Scharl, M. M., Krämer, S. D., Rogler, G., Hersberger, M., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000412 · Cited by 13
Updating the Role of α-Cell Preproglucagon products on GLP-1 receptor–mediated insulin secretion
Sandoval, D. (2020) · Diabetes · doi:10.2337/dbi19-0027 · Cited by 12
Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion
Bethea, M. M., Bozadjieva-Kramer, N., & Sandoval, D. A. (2021) · Endocrinology · doi:10.1210/endocr/bqab150 · Cited by 12
Visa, M., & Berggren, P. (2024) · Diabetologia · doi:10.1007/s00125-024-06173-w · Cited by 12
A Lipocalin-Derived Peptide Modulating Fibroblasts and Extracellular Matrix Proteins
Carrijo-Carvalho, L. C., Maria, D. A., Ventura, J. S., Morais, K. L. P., Melo, R. L. D., Rodrigues, C. J., & Chudzinski‐Tavassi, A. M. (2012) · Journal of Toxicology · doi:10.1155/2012/325250 · Cited by 12
“There are also reports describing the involvement of IL-1 [46] and IL-6/IL-6R [47] in antiapoptotic responses.”
BackgroundAn optical method to evaluate both mass and functional competence of pancreatic α- and β-cells
Wang, Y., Han, C., Zhu, W., Wu, Z., Liu, Y., & Chen, L. (2016) · Journal of Cell Science · doi:10.1242/jcs.184523 · Cited by 12
Hoevenaar, M., Goossens, D., & Roorda, J. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320979097 · Cited by 12
Tian, Y., Wang, Z., Zheng, X., Song, W., Cai, L., Rane, M. J., & Zhao, Y. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115654 · Cited by 12
IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases
Zhao, J., Turpin-Nolan, S. M., & Febbraio, M. A. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155549 · Cited by 12
Beneficial islet inflammation in health depends on pericytic TLR/MyD88 signaling
Schonblum, A., Naser, D. A., Ovadia, S., Egbaria, M., Puyesky, S., Epshtein, A., Wald, T., Mercado-Medrez, S., Ashery‐Padan, R., & Landsman, L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179335 · Cited by 11
Metadata
- Authors
- Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y.
- Affiliations
- University Hospital Zurich (CH)
- University of Geneva (CH)
- Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium;
- KU Leuven (BE)
- Diabetes Research Center, Brussels Free University, Laarbeeklaan 103, B-1090 Brussels, Belgium; and
- Inserm (FR)
- **Cell Therapy of Diabetes, ERIT-M 0106, Institut National de la Santé et de la Recherche Médicale, Faculty of Medicine, 1 Place de Verdun, 59045 Lille, France
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13163-13168
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529061
- OpenAlex
- W2032658955
- Cited by
- 269
- References
- 40
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 21 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 22 · 2014: 18 · 2013: 23 · 2012: 17
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- interleukin-6, alpha cells, IL-6 receptor, glucagon secretion, alpha-cell proliferation, high-fat diet, type 2 diabetes, beta-cell compensation, insulin secretion, obesity, islets
- MeSH terms
- Animals, Dietary Fats, Feeding Behavior, Gene Expression Regulation, Glucagon, Glucose Tolerance Test, Humans, Male, Mice, Inbred C57BL, Phosphorylation, Protein Precursors, RNA, Messenger, Interleukin-6, Rats, Wistar, Apoptosis, Mice, Knockout, Receptors, Interleukin-6, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, STAT3 Transcription Factor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.